Stem cell therapeutics - Reality versus hype and hope

Journal of Assisted Reproduction and Genetics

Volumn 28, Issue 4, 2011, Pages 287-290

  Zech, Nicolas H ^a   Preisegger, Karl Heinz ^b   Hollands, Peter ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b Vivocell Biosolutions   (Austria)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Adult; Cord blood; Embryonic; iPS cells; Stem cells; Therapy; Transplantation

Indexed keywords

CELL CULTURE; CELL THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; ECTODERM; GENE THERAPY; GENETIC TRANSFECTION; INNER CELL MASS; MESENCHYMAL STEM CELL; NOTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELLS; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

IPS;

EID: 79960282223     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-010-9520-6     Document Type: Note

References (38)

1. AK Teo L Vallier 2010 Emerging use of stem cells in regenerative medicine Biochem J 428 1 11 23 20423328 10.1042/BJ20100102 1:CAS:528: DC%2BC3cXlt1Cmsbg%3D
2. W Deng 2010 Exploiting pluripotency for therapeutic gain Panminerva Med 52 2 167 73 20517198
3. CJ Lengner 2010 iPS cell technology in regenerative medicine Ann N Y Acad Sci 1192 38 44 20392216 10.1111/j.1749-6632.2009.05213.x 1:CAS:528: DC%2BC3cXmsVSrs70%3D
4. MJ Evans MH Kaufman 1981 Establishment in culture of pluripotential cells from mouse embryos Nature 292 154 6 7242681 10.1038/292154a0 1:STN:280:DyaL3M3itV2qsg%3D%3D (Pubitemid 11050741)
5. P Hollands 1987 Differentiation and grafting of haemopoietic stem cells from early post-implantation mouse embryos Development 99 69 76 2888640 1:STN:280:DyaL1c%2FgsVWmtw%3D%3D (Pubitemid 17045735)
6. P Hollands 1988 Differentiation of embryonic haemopoietic stem cells from mouse blastocysts grown in vitro Development 102 135 41 3416770 1:STN:280:DyaL1czivVOruw%3D%3D (Pubitemid 18063183)
7. P Hollands 1988 Transplantation of embryonic haemopoietic stem cells without prior recipient X-irradiation Br J Haem 70 157 63 10.1111/j.1365-2141. 1988.tb02457.x 1:STN:280:DyaL1M%2FltVyiuw%3D%3D
8. JA Thomson J Itskovitz-Eldor SS Shapiro MA Waknitz JJ Swiergiel VS Marshall JM Jones 1998 Embryonic stem cell lines derived from human blastocysts Science 282 1145 7 9804556 10.1126/science.282.5391.1145 1:CAS:528: DyaK1cXntleisLg%3D (Pubitemid 28516247)
9. S Koestenbauer NH Zech H Juch P Vanderzwalmen L Schoonjans G Dohr 2006 Embryonic stem cells: similarities and differences between human and murine embryonic stem cells Am J Reprod Immunol 55 3 169 80 16451351 10.1111/j.1600-0897.2005.00354.x 1:CAS:528:DC%2BD28XjtlWlsL4%3D (Pubitemid 43329493)
10. H Niwa T Burdon I Chambers A Smith 1998 Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3 Genes Dev 12 13 2048 60 9649508 10.1101/gad.12.13.2048 1:CAS:528:DyaK1cXksFygtbk%3D (Pubitemid 28323878)
11. QL Ying J Nichols I Chambers A Smith 2003 BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3 Cell 115 3 281 92 14636556 10.1016/S0092-8674(03)00847- X 1:CAS:528:DC%2BD3sXovFClu7c%3D (Pubitemid 37487702)
12. GM Beattie AD Lopez N Bucay A Hinton MT Firpo CC King A Hayek 2005 Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers Stem Cells 23 4 489 95 15790770 10.1634/stemcells.2004-0279 1:CAS:528:DC%2BD2MXjslGjsrY%3D (Pubitemid 40478488)
13. D James AJ Levine D Besser A Hemmati-Brivanlou 2005 TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells Development 132 6 1273 82 15703277 10.1242/dev.01706 1:CAS:528:DC%2BD2MXjsFentLs%3D (Pubitemid 40528787)
14. RH Xu RM Peck DS Li X Feng T Ludwig JA Thomson 2005 Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells Nat Methods 2 3 185 90 15782187 10.1038/nmeth744 1:CAS:528: DC%2BD2MXisVGisrc%3D (Pubitemid 41122125)
15. ME Levenstein TE Ludwig RH Xu RA Llanas K VanDenHeuvel-Kramer D Manning JA Thomson 2006 Basic fibroblast growth factor support of human embryonic stem cell self-renewal Stem Cells 24 3 568 74 16282444 10.1634/stemcells.2005-0247 1:CAS:528:DC%2BD28XhtFKitbjL (Pubitemid 44464760)
16. L Xiao X Yuan SJ Sharkis 2006 Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells Stem Cells 24 6 1476 86 16456129 10.1634/stemcells.2005-0299 1:CAS:528:DC%2BD28XhtFKlsbbM (Pubitemid 44464664)
17. B Greber H Lehrach J Adjaye 2007 Stem Cells. Fibroblast growth factor 2 modulates transforming growth factor beta signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal Stem Cells 25 2 455 64 17038665 10.1634/stemcells.2006-0476 1:CAS:528:DC%2BD2sXivVOlt7g%3D (Pubitemid 46232801)
18. MA Surani G Durcova-Hills P Hajkova K Hayashi WW Tee 2008 Germ line, stem cells, and epigenetic reprogramming Cold Spring Harb Symp Quant Biol 73 9 15 19022742 10.1101/sqb.2008.73.015 1:CAS:528:DC%2BD1MXos1ersbY%3D
19. Y Xu X Zhu HS Hahm W Wei E Hao A Hayek S Ding 2010 Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules Proc Natl Acad Sci U S A 107 18 8129 34 20406903 10.1073/pnas.1002024107 1:CAS:528:DC%2BC3cXmtVKgsb8%3D
20. ST Rashid L Vallier 2010 Induced pluripotent stem cells-alchemist's tale or clinical reality? Expert Rev Mol Med 12 25 35 20707936 10.1017/ S1462399410001596
21. ML Berger D Grainger 2010 Comparative effectiveness research: the view from a pharmaceutical company Pharmacoeconomics 28 10 915 22 20831299 10.2165/11535400-000000000-00000
22. NH Zech A Shkumatov S Koestenbauer 2007 The magic behind stem cells J Assist Reprod Genet 24 6 208 14 17385026 10.1007/s10815-007-9123-z (Pubitemid 47202800)
23. A Matheu C Pantoja A Efeyan LM Criado J Martín-Caballero JM Flores P Klatt M Serrano 2004 Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging Genes Dev 18 22 2736 46 15520276 10.1101/gad.310304 1:CAS:528:DC%2BD2cXhtVCjt7%2FM (Pubitemid 39507767)
24. A Banito ST Rashid JC Acosta S Li CF Pereira I Geti S Pinho JC Silva V Azuara M Walsh L Vallier J Gil 2009 Senescence impairs successful reprogramming to pluripotent stem cells Genes Dev 23 18 2134 9 19696146 10.1101/gad.1811609 1:CAS:528:DC%2BD1MXht1ersbrL
25. H Li M Collado A Villasante K Strati S Ortega M Cañamero MA Blasco M Serrano 2009 The Ink4/Arf locus is a barrier for iPS cell reprogramming Nature 460 7259 1136 9 19668188 10.1038/nature08290 1:CAS:528:DC%2BD1MXps1ahtLg%3D
26. A Trounson R Klein R Murphy 2008 Stem cell research in California: the game is on Cell 132 4 522 4 18295567 10.1016/j.cell.2008.02.014 1:CAS:528:DC%2BD1cXivVagsbo%3D (Pubitemid 351253703)
27. N Scolding 2005 Stem-cell therapy: hope and hype Lancet 365 9477 2073 5 15964432 10.1016/S0140-6736(05)66554-3 (Pubitemid 40826954)
28. http://news.bbc.co.uk/2/hi/science/nature/4213566.stm
29. http://stemcellresearchinformation.com/japans-stemcell-pioneer-grapples- pressure-success-444968a
30. http://www.geron.com/media/pressview.aspx?id=1235
31. http://www.nature.com/news/2009/090507/full/news.2009.455.html
32. http://www.nature.com/news/2009/090127/full/457516a.html
33. http://parentsguidecordblood.org/content/usa/medical/diseases.shtml
34. DT Harris 2008 Cord blood stem cells: worth the investment Nat Rev Cancer 8 10 823 18813324 10.1038/nrc2418-c2 1:CAS:528:DC%2BD1cXhtFCrtbrI
35. L Sensebé P Bourin 2009 Mesenchymal stem cells for therapeutic purposes Transplantation 87 9 Suppl S49 53 19424006 10.1097/TP.0b013e3181a28635
36. P Ljungman M Bregni M Brune J Cornelissen T de Witte G Dini H Einsele HB Gaspar A Gratwohl J Passweg C Peters V Rocha R Saccardi H Schouten A Sureda A Tichelli A Velardi European Group for Blood and Marrow Transplantation 2010 Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 Bone Marrow Transplant 45 2 219 34 19584824 10.1038/bmt.2009.141 1:STN:280: DC%2BC3c%2FpsFyjuw%3D%3D
37. http://www.nytimes.com/2004/05/29/us/therapy-impasse-cancer-hope- deferred-blood-treatment-s-promise-mired-bureaucracy.html
38. A Scaradavou KM Smith R Hawke A Schaible M Abboud NA Kernan JW Young JN Barker 2010 Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation Biol Blood Marrow Transplant 16 4 500 8 19932758 10.1016/j.bbmt.2009.11.013